Functional expression of Fas antigen (CD95) on hematopoietic progenitor cells

Blood

Volumn 86, Issue 3, 1995, Pages 883-889

  Nagafuji, Koji ^a   Shibuya, Tsunefumi ^b   Harada, Mine ^b   Mizuno, Shin Ichi ^b   Takenaka, Katsuto ^b   Miyamoto, Toshihiro ^b   Okamura, Takashi ^b   Gondo, Hisashi ^b   Niho, Yoshiyuki ^b  

^a KYUSHU UNIVERSITY   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; CD34 ANTIGEN; DNA FRAGMENT; GAMMA INTERFERON; IMMUNOGLOBULIN M ANTIBODY; MESSENGER RNA; MONOCLONAL ANTIBODY; RECOMBINANT STEM CELL FACTOR; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR;

ANTIGEN EXPRESSION; ARTICLE; BURST FORMING UNIT E; CELL COUNT; CELL DEATH; CELL ISOLATION; CELL STRUCTURE; CELL VIABILITY; COLONY FORMING CELL; COLONY FORMING UNIT GM; CONTROLLED STUDY; CULTURE MEDIUM; GENE INDUCTION; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

EID: 0029166876     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v86.3.883.bloodjournal863883     Document Type: Article

References (35)

1. Kerr JFR, Wyllie AH, Currie AR: Apoptosis: A basic biological phenomenon with wide ranging implications in tissue kinetics. Br J Cancer 26:239, 1972
2. Wyllie AH, Kerr JFR, Currie AR: Cell death: The significance of apoptosis. Int Rev Cytol 68:251, 1980
3. Koury MJ: Programmed cell death (apoptosis) in hematopoiesis. Exp Hematol 20:391, 1992
4. Yonehara S, Ishii A, Yonehara M: A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor. J Exp Med 169:1747, 1989
5. Itoh N. Yonehara S, Ishii A, Yonehara M, Mizushima S, Sameshima M, Hase A, Seto Y, Nagata S: The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell 66:233, 1991
6. Oehm A, Behrmann I, Falk W, Pawlita M, Maier G, Klas C, Li-Weber M, Richrds S, Dhein J, Trauth BC, Ponsting H, Krammer PH: Purification and molecular cloning of the Apo-1 cell surface antigen, a member of the tumor necrosis factor/nerve growth factor receptor superfamily. J Biol Chem 267:10709, 1992
7. Watanabe-Fukunaga R, Brannan CI, Copeland NG, Jerkins NA, Nagata S: Lymphoproliferation disorder in mice explained by the defects in Fas antigen that mediate apoptosis. Nature 356:314, 1992
8. Baum CM. Weissman IL, Tsukamoto AS, Buckle AM, Peault B: Isolation of a candidate human hematopoietic stem cell population. Proc Natl Acad Sci USA 89:2804, 1992
9. Iwai K, Miyawaki T, Takazaki T, Konno A, Ohta K, Yachie A. Seki H, Taniguchi N: Differential expression of bcl-2 and susceptibility to anti-Fas-mediated cell death in peripheral blood lymphocytes, monocytes, and neutrophils. Blood 84:1201, 1994
10. Nagafuji K, Harada M, Teshima T, Eto T, Takamatsu Y, Okamura T, Murakawa M, Akashi K, Niho Y: Hematopoietic progenitor cells from patients with adult T-cell leukemia-lymphoma are not infected with human T-cell leukemia virus type I. Blood 82:2823, 1993
11. Brockhous M, Schoenfeld HJ, Schlaeger EJ, Hunziker W, Lesslauer W, Loeescher H: Identification of two types of tumor necrosis factor receptors on human cell lines by monoclonal antibodies. Proc Natl Acad Sci USA 87:3127, 1990
12. Taniguchi S, Shibuya T, Morioka E, Okamura T, Okamura S, Inaba S, Niho Y: Demonstration of three distinct immunological disorders on erythropoiesis in a patient with pure red cell aplasia and autoimmune haemolytic anaemia associated with thymoma. Br J Haematol 68:473, 1988
13. Chomczynski P, Sacchi N: Single step method of RNA isolation by acid guanidine thiocyanate phenol chloroform extraction. Anal Biochem 162:156, 1987
14. Nagafuji K, Harada M, Takamatsu Y, Eto T, Teshima T, Kamura T, Okamura T, Hayashi S, Akashi K, Niho Y: Evaluation of leukaemic contamination in peripheral blood stem cell harvests by reverse transcriptase polymerase chain reaction. Br J Haematol 85:578, 1993
15. Ponte P, Ng S, Engel J, Gunning P, Kedes L: Evolutionary conservation of untranslated region of actin mRNA: DNA sequence of a human β-actin cDNA. Nucleic Acids Res 12:1687, 1984
16. Rodriguez-Tarduchy G, Collins M, Lopez-Rivas A: Regulation of apoptosis in interleukin-3 dependent hematopoietic cells by interleukin-3 and calcium ionophore. EMBO J 9:2997, 1990
17. Koury MJ, Bondurant MC: Erythropoietin retards DNA breakdown and prevents programmed cell death in erythroid progenitor cells. Science 248:378, 1990
18. Williams GT, Smith CA, Spooner E, Dextar TM, Taylor DR: Haematopoietic colony stimulating factors promote cell survival by suppressing apoptosis. Nature 343:76, 1990
19. Yu H, Bauer B, Lipke GK, Phillips RL, Zant GV: Apoptosis and hematopoiesis in murine fetal liver. Blood 81:373, 1993
20. Suda T, Suda J, Ogawa M: Permissive role of interleukin-3 (IL-3) in proliferation and differentiation of multipotential hematopoietic progenitors in culture. J Cell Physiol 124:182, 1985
21. Leary AG, Wong GG, Clark SC, Smith AG, Ogawa M: Leukemia inhibitory factor differentiation-inhibiting activity/human interleukin for DA cells auguments proliferation of human hematopoietic stem cells. Blood 75:1960, 1990
22. Katayama N, Clark SC, Ogawa M: Growth factor requirement for survival in cell-cycle dormancy of primitive murine lymphohematopoietic progenitors. Blood 81:610, 1993
23. Brandt JE, Bhalla K, Hoffman R: Effect of interleukin-3 and c-kit ligand on survival of various classes of human hematopoietic progenitor cells. Blood 83:1507, 1994
24. Mangan DF, Welch GR, Wahl SM: Lipopolysaccharide, tumor necrosis factor a, and IL-I β prevent programmed cell death (apoptosis) in human peripheral blood monocytes. J Immunol 146:1541, 1991
25. Savill JS, Wyllie AH, Henson JE, Walport MJ, Henson PM, Haslett C: Macrophage phagocytosis of aging neutrophils in inflammation. J Clin Invest 83:865, 1989
26. Stern M, Meagher L, Savill J, Haslett C: Apoptosis in human eosinophils leads to phagocytosis by macrophage and is modulated by IL-5. J Immunol 148:3543, 1992
27. Elbaz O, Buddel LM, Hoogerburgge H, Towe P, Delwel R, Mahmoud LA, Lowenberg B: Tumor necrosis factor regulates the expression of granulocyte-macrophage colony-stimulating factor and interleukin-3 receptors on human acute myeloid leukemia cells. Blood 77:989, 1991
28. Elbaz O, Buddel LM, Hoogerburgge H, Towe P, Delwel R, Mahmoud LA, Lowenberg B: Tumor necrosis factor downregulates granulocyte colony-stimulating factor receptor expression on human acute myeloid leukemia cells and granulocytes. J Clin Invest 87:838, 1991
29. Delwel R, Buitenen CV, Loewenberg B, Towe P: Involvement of tumor necrosis factor receptors p55 and p75 in TNF responses of acute myeloid leukemia blasts in vitro. Blood 80:1798, 1992
30. + cells. Blood 84:2506, 1994
31. Tartaglia LA, Rothe M, Hu YF, Goeddel DV: Tumor necrosis factor's cytotoxic activity is signaled by the p55 TNF receptor. Cell 73:213, 1993
32. Cohen PL, Eisenberg A: The lpr and gld genes in systemic autoimmunity: life and death in the Fas lane. Immunol Today 13:427, 1992
33. Allen RD, Marshall JD, Roths JB, Sidman CL: Differences defined by bone marrow transplantation suggest that lpr and gld are mutations of genes encoding an interacting pair of molecules. J Exp Med 172:1367, 1990
34. Suda T, Takahashi T, Golstein P, Nagata S: Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family. Cell 75:1169, 1993
35. Takahashi T, Tanaka M, Brannan CI, Jenkins NA, Copeland NG, Suda T, Nagata S: Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand. Cell 76:969, 1994